Arylphthalazines: Identification of a new phthalazine chemotype as inhibitors of VEGFR kinase
- 1 November 2005
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (21), 4696-4698
- https://doi.org/10.1016/j.bmcl.2005.07.064
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Novel 4-Anilinoquinazolines with C-7 Basic Side Chains: Design and Structure Activity Relationship of a Series of Potent, Orally Active, VEGF Receptor Tyrosine Kinase InhibitorsJournal of Medicinal Chemistry, 2002
- Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapyInternational Journal of Cancer, 2001
- Synthesis of 4-Aryl-1-(3-methylpiperazin-1-yl)phthalazines by Suzuki-type Cross-coupling ReactionSynthesis, 2001
- New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven AngiogenesisJournal of Medicinal Chemistry, 2000
- Mechanisms of angiogenesisNature, 1997
- Regulators of AngiogenesisAnnual Review of Physiology, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990